SCHEMBL9204064

SCHEMBL9204064

CC(C)OC(=O)c1cc(NC(=O)c2c(Br)c(Br)c(Br)c(Br)c2C(=O)O)c(F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 3/20 0.39
HPGD P15428 2/20 0.39
WDR5 P61964 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ENPP2 Q13822 1/20 0.35
DHODH Q02127 1/20 0.35
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
ACLY P53396 2/20 0.34
PTGFR P43088 1/20 0.34
POLB P06746 1/20 0.34
PYGL P06737 1/20 0.34
TP53 P04637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198278 0.81 MAPT (0.46) SMN1; SMN2MAPTLMNANPC1RAB9A
SCHEMBL8930017 0.80 NPC1 (0.53) SMN1; SMN2MAPTLMNANPC1RAB9A
SCHEMBL10647200 0.78 MAPT (0.46) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL8930238 0.76 LMNA (0.44) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL10421286 0.75 LMNA (0.42) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL11020212 0.75 LMNA (0.48) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL11206454 0.74 NPSR1 (0.42) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL31118290 0.73 LMNA (0.45) SMN1; SMN2MAPTLMNAHPGDNPC1
SCHEMBL13981047 0.73 LMNA (0.47) SMN1; SMN2MAPTLMNAHPGDWDR5
SCHEMBL9247954 0.72 HPGD (0.56) SMN1; SMN2MAPTLMNAHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN disclosed